VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$2.28
-0.31 (-11.97%)
As of Feb 8, 2:30 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.38M 3.56M 2.77M
Net Income 377.1K 452.9K 261.8K
EPS
Profit Margin 11.2% 12.7% 9.5%
Rev Growth -0.5% +0.2% +7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.43M 2.21M 2.49M
Total Equity 5.08M 4.37M 4.42M
D/E Ratio 0.48 0.51 0.56
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 421.0K 509.0K 375.7K
Free Cash Flow 454.1K 445.4K 284.4K